Outcomes of Chronic Hepatitis C Treatment in The Infectious Diseases Hospital Iasi
Chronic hepatitis C is an important cause of morbidity and mortality due o hepatic disease. Material and method The retrospectively studied the evolution of 30 patients with chronic hepatitis C, treated in the Infectious Diseases Hospital of Iasi, with Peginterferon and Ribavirin for 48 weeks. Resul...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Romanian Society of Oral Rehabilitation
2012-10-01
|
| Series: | Romanian Journal of Oral Rehabilitation |
| Online Access: | http://www.rjor.ro/outcomes-of-chronic-hepatitis-c-treatment-in-the-infectious-diseases-hospital-iasi/?lang=ro |
| _version_ | 1819135203202826240 |
|---|---|
| author | Mihaela Catalina Luca A. Vata A. Luca Carmen Dorobat |
| author_facet | Mihaela Catalina Luca A. Vata A. Luca Carmen Dorobat |
| author_sort | Mihaela Catalina Luca |
| collection | DOAJ |
| description | Chronic hepatitis C is an important cause of morbidity and mortality due o hepatic disease. Material and method The retrospectively studied the evolution of 30 patients with chronic hepatitis C, treated in the Infectious Diseases Hospital of Iasi, with Peginterferon and Ribavirin for 48 weeks. Results 18 patients were treated with Peginterferon α2a and Ribavirin, and 12 with Peginterferon α2b and Ribavirin. Most of them (73.3%) were adults, aged between 30 and 50 years, with a sex ratio M/F – 13/17. Most of them had risk factors for the transmission of HCV: 28 of them suffered surgery and 2 of them had infected sexual partners. 3 patients didn’t achieve a rapid virusologic response and 6 patients were relapsers. All the other 70% of patients had a sustained virologic response. The side effects were present in all patients, with a moderate intensity. Conclusion The success (SVR) rate of antiviral therapy was higher than expected (especially for genotype 1 HCV). The patients with a viral relapse could be soon treated with the new protease inhibitors and hope for a cure. |
| first_indexed | 2024-12-22T10:15:21Z |
| format | Article |
| id | doaj.art-94def166cc3a4ec6bd5f45f35d0b6e24 |
| institution | Directory Open Access Journal |
| issn | 2066-7000 2601-4661 |
| language | English |
| last_indexed | 2024-12-22T10:15:21Z |
| publishDate | 2012-10-01 |
| publisher | Romanian Society of Oral Rehabilitation |
| record_format | Article |
| series | Romanian Journal of Oral Rehabilitation |
| spelling | doaj.art-94def166cc3a4ec6bd5f45f35d0b6e242022-12-21T18:29:44ZengRomanian Society of Oral RehabilitationRomanian Journal of Oral Rehabilitation2066-70002601-46612012-10-01434850Outcomes of Chronic Hepatitis C Treatment in The Infectious Diseases Hospital IasiMihaela Catalina Luca0A. Vata1A. Luca2Carmen Dorobat3Faculty of Dental Medicine, University of Medicine and Pharmacy "Grigore T. Popa" - Iasi, RomaniaFaculty of Dental Medicine, University of Medicine and Pharmacy "Grigore T. Popa" - Iasi, RomaniaFaculty of Dental Medicine, University of Medicine and Pharmacy "Grigore T. Popa" - Iasi, RomaniaFaculty of Dental Medicine, University of Medicine and Pharmacy "Grigore T. Popa" - Iasi, RomaniaChronic hepatitis C is an important cause of morbidity and mortality due o hepatic disease. Material and method The retrospectively studied the evolution of 30 patients with chronic hepatitis C, treated in the Infectious Diseases Hospital of Iasi, with Peginterferon and Ribavirin for 48 weeks. Results 18 patients were treated with Peginterferon α2a and Ribavirin, and 12 with Peginterferon α2b and Ribavirin. Most of them (73.3%) were adults, aged between 30 and 50 years, with a sex ratio M/F – 13/17. Most of them had risk factors for the transmission of HCV: 28 of them suffered surgery and 2 of them had infected sexual partners. 3 patients didn’t achieve a rapid virusologic response and 6 patients were relapsers. All the other 70% of patients had a sustained virologic response. The side effects were present in all patients, with a moderate intensity. Conclusion The success (SVR) rate of antiviral therapy was higher than expected (especially for genotype 1 HCV). The patients with a viral relapse could be soon treated with the new protease inhibitors and hope for a cure.http://www.rjor.ro/outcomes-of-chronic-hepatitis-c-treatment-in-the-infectious-diseases-hospital-iasi/?lang=ro |
| spellingShingle | Mihaela Catalina Luca A. Vata A. Luca Carmen Dorobat Outcomes of Chronic Hepatitis C Treatment in The Infectious Diseases Hospital Iasi Romanian Journal of Oral Rehabilitation |
| title | Outcomes of Chronic Hepatitis C Treatment in The Infectious Diseases Hospital Iasi |
| title_full | Outcomes of Chronic Hepatitis C Treatment in The Infectious Diseases Hospital Iasi |
| title_fullStr | Outcomes of Chronic Hepatitis C Treatment in The Infectious Diseases Hospital Iasi |
| title_full_unstemmed | Outcomes of Chronic Hepatitis C Treatment in The Infectious Diseases Hospital Iasi |
| title_short | Outcomes of Chronic Hepatitis C Treatment in The Infectious Diseases Hospital Iasi |
| title_sort | outcomes of chronic hepatitis c treatment in the infectious diseases hospital iasi |
| url | http://www.rjor.ro/outcomes-of-chronic-hepatitis-c-treatment-in-the-infectious-diseases-hospital-iasi/?lang=ro |
| work_keys_str_mv | AT mihaelacatalinaluca outcomesofchronichepatitisctreatmentintheinfectiousdiseaseshospitaliasi AT avata outcomesofchronichepatitisctreatmentintheinfectiousdiseaseshospitaliasi AT aluca outcomesofchronichepatitisctreatmentintheinfectiousdiseaseshospitaliasi AT carmendorobat outcomesofchronichepatitisctreatmentintheinfectiousdiseaseshospitaliasi |